(Q71968631)

English

Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia

scientific article published on 01 January 1996

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

title

Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

Heresco-Levy U

1

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

Silipo G

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

Javitt DC

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

publication date

1 January 1996

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

published in

Psychopharmacology Bulletin

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

volume

32

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

page(s)

731-740

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

retrieved

22 October 2019

Identifiers

PubMed ID

8993096

1 reference

stated in

Europe PubMed Central

PubMed ID

8993096

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8993096%20AND%20SRC:MED&resulttype=core&format=json

(Q71968631)

Glycinergic augmentation of NMDA receptor-mediated neurotransmission in the treatment of schizophrenia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)